3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks are worth checking out right now. Here's why.
The 10 Biggest Consumer Staples Stocks
These companies dominate one of investors' favorite business niches.
Kinder Morgan Flattens Out in Q2
The pipeline giant's results came in a bit lighter than anticipated.
Just because AT&T, Shell, and Altria have high yields doesn't necessarily make them high risk.
Endeavor may present risks to IPO investors, but it does hold a portfolio of enviable assets.
Strong revenue potential is balanced out by a clouded earnings picture at this well-known IPO candidate.
An overview of the sprawling talent agency and content giant.
The digital payment processor is expanding its money transfer service into 32 markets across Europe.
Back in June 2017, Wall Street was riding high.
Back in July 2018, David Gardner picked these as investments to hold for four years -- till the next World Cup.
It’s been just over three years since U.K. citizens cast their votes for “leave." It’s also this podcast's fourth birthday.
Can cloud computing pick up the slack as growth in Google ad sales slows?
Universal Display, American Express, and SeaWorld Entertainment managed to hit fresh multiyear highs just as the market was also moving higher last week.
After a couple of so-so bank earnings reports, Goldman Sachs gives investors something to celebrate.
The largest U.S. bank just reported its latest results, and they’re a mixed bag.
Despite not being allowed to grow in size and a challenging interest rate environment, Wells Fargo delivered a strong second quarter.
Despite the upbeat narrative from Wall Street, on Main Street, people are fearful about the next economic downturn.
The ad-buying platform specialist's revenue and adjusted earnings-per-share growth have both been tremendous recently. Did this momentum persist in Q2?
The cybersecurity stock has been on a relentless run since its debut in March 2018.
Can Apple return to growth?
If you're a valued employee, your manager might stop at nothing to get you to stay -- even when you're eager to leave.
Avoid the crowds to enjoy strong returns with PetMed, Capcom, and Tredegar.
OrganiGram remains on track to complete its Moncton campus by year's end, and is eagerly awaiting the launch of derivative cannabis products in December.